Ozuriftamab

• Target :

  ADC Antibody|||ROR

• Related Pathways :

  Antibody-drug Conjugate/ADC Related|||Metabolism

• Purity :

  0.977

• Bioactivity :

  Ozuriftamab (BA302) is a human immunoglobulin IgG1 kappa monoclonal antibody specifically designed to target the receptor tyrosine kinase-like orphan receptor 2 (ROR2), and this antibody serves as the foundational targeting moiety for the synthesis of antibody-drug conjugates (ADCs), such as Ozuriftamab vedotin.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2460399-44-2